Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VITRIS.at Study of arginine vasopressin versus saline placebo in refractory traumatic hemorrhagic shock
2006-004252-20Phase 3Completed
- Sponsor
- University Clinic for Anesthesiology and Intensive Care Medicine, Innsbruck
- Start
- Mar 2008
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial in hemorrhagic shock comparing Arginine vasopressin plus standard shock treatment with Saline placebo plus standard shock treatment (2 arms). Primary endpoint: Hospital admission rate. Started Mar 2008; status: completed.
02
Drugs
vasopressin
03
Conditions
hemorrhagic shock
Beyond the preview
Go deeper on 2006-004252-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004252-20.